Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Cancer Research and Clinical Oncology|July 8, 2020
First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutationThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.
Clinical Genitourinary Cancer|June 23, 2019
Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysisThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.
Therapeutic Advances in Medical Oncology|December 21, 2020
First-line immune-checkpoint inhibitor plus chemotherapy <i>versus</i> chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysisThierry Landre, Kader Chouahnia, Gaëtan Des Guetz, et al.
Frontiers in Oncology|August 12, 2022
Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case reportPascal Wang, Emmanuelle Fabre, Antoine Martin, et al.
Expert Review of Anticancer Therapy|May 30, 2024
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced <i>EGFR</i>-mutated NSCLC: a meta-analysis of randomized phase III trialsThierry Landre, Jean-Baptiste Assié, Kader Chouahnia, et al.
JTO Clinical and Research Reports|June 15, 2026
Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-AnalysisThierry Landre, Jean-Baptiste Assié, Kader Chouahnia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 12, 2013
Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapyMichael Soussan, Kader Chouahnia, Jacques-Antoine Maisonobe, et al.
Gastroenterology Research and Practice|November 14, 2013
Impact of physical activity on cancer-specific and overall survival of patients with colorectal cancerGaetan Des Guetz, Bernard Uzzan, Thierry Bouillet, et al.
Bulletin Du Cancer|October 14, 2022
[Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives]Pascal Wang, Boris Duchemann, Kader Chouahnia, et al.
Cancer Immunology, Immunotherapy : CII|August 11, 2021
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trialsThierry Landre, Gregoire Justeau, Jean-Baptiste Assié, et al.
Pageof 4